Aspen Neuroscience
Aspen Neuroscience is a series a startup based in United States. 1 investor tracked.
About Aspen Neuroscience
Aspen Neuroscience is a startup founded in 2016 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Aspen Neuroscience is a clinical-stage biotechnology company developing autologous induced pluripotent stem cell (iPSC)-derived neuron replacement therapies for Parkinson’s disease. Their lead product, ANPD001 (Sasineprocel), aims to restore dopamine function and rebuild neural networks using personalized regenerative therapies derived from a patient’s own skin cells.
Explore Aspen Neuroscience's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.